National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 9/17/2021 release of VAERS data:

Found 10,052 cases where Vaccine is MENB



Case Details

This is page 33 out of 1,006

Result pages: prev   24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42   next


VAERS ID: 620329 (history)  
Form: Version 1.0  
Age: 16.0  
Sex: Male  
Location: Ohio  
Vaccinated:2016-01-18
Onset:2016-01-19
   Days after vaccination:1
Submitted: 2016-01-22
   Days after onset:3
Entered: 2016-01-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
FLUN4: INFLUENZA (SEASONAL) (FLUMIST QUADRIVALENT) / MEDIMMUNE VACCINES, INC. FL2115 / UNK NS / IN
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS 148901A / UNK LA / IM

Administered by: Unknown       Purchased by: Public
Symptoms: Headache, Hypoaesthesia, Intervertebral disc disorder, Nuclear magnetic resonance imaging brain normal, Nuclear magnetic resonance imaging spinal abnormal, Paraesthesia, Spinal osteoarthritis
SMQs:, Peripheral neuropathy (broad), Guillain-Barre syndrome (broad), Arthritis (narrow), Sexual dysfunction (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 6 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Claritin, Ibuprofen, MiraLax
Current Illness: No
Preexisting Conditions: None
Allergies:
Diagnostic Lab Data: MRI w/o contract of Cervical spine - negative; MRI Lumbar spine w/o contrast -mild degenerative changes at L4-5 and L5-S1; MRI Thoracic spine- mild prominence of central canal mid thoracic spine on the cord of doubtful significance. Few Schmorl''s nodes of the mid thoracic spine noted otherwise unremarkable MRI of the thoracic spine. MRI Brain w/o contrast-no evidence of an acute intracranial process or mass or abn signal in the brain
CDC Split Type:

Write-up: Patient awoke with headache, numbness and tingling of lower extremities and fingers both hands. Seen in PCP office that morning and admitted to hospital for evaluation.


VAERS ID: 620400 (history)  
Form: Version 1.0  
Age: 16.0  
Sex: Female  
Location: Unknown  
Vaccinated:2015-09-04
Onset:2015-09-04
   Days after vaccination:0
Submitted: 2016-01-22
   Days after onset:140
Entered: 2016-01-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (TRUMENBA) / PFIZER/WYETH L13514 / 1 RA / IM
MNQ: MENINGOCOCCAL CONJUGATE (MENVEO) / NOVARTIS VACCINES AND DIAGNOSTICS M14072 / 2 LA / IM

Administered by: Other       Purchased by: Other
Symptoms: Extra dose administered, Gait disturbance, Photosensitivity reaction, Seizure
SMQs:, Peripheral neuropathy (broad), Systemic lupus erythematosus (broad), Anticholinergic syndrome (broad), Convulsions (narrow), Parkinson-like events (broad), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Generalised convulsive seizures following immunisation (narrow), Hypersensitivity (broad), Medication errors (narrow), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? Yes, 10 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions: 06/03/2011, MENVEO, Prophylaxis, 1st dose received on 3rd June 2011
Allergies:
Diagnostic Lab Data:
CDC Split Type: US2016GSK004392

Write-up: This case was reported by a physician via other manufacturer and described the occurrence of seizure in a 16-year-old female patient who received MENVEO (batch number M14072, expiry date 30th November 2015). Co-suspect products included Meningococcal B vaccine (batch number L13514, expiry date 31st July 2016). Previously administered products included MENVEO (1st dose received on 3rd June 2011). On 4th September 2015, the patient received the 2nd dose of MENVEO (intramuscular) .5 ml and the 1st dose of Meningococcal B vaccine (intramuscular) .5 ml. On 4th September 2015, less than a day after receiving MENVEO, the patient experienced seizure (serious criteria hospitalization and GSK medically significant), photosensitivity, walking difficulty and extra dose administered. Meningococcal B vaccine was discontinued. On an unknown date, the outcome of the seizure, photosensitivity and walking difficulty were recovering/resolving and the outcome of the extra dose administered was unknown. It was unknown if the reporter considered the seizure, photosensitivity and walking difficulty to be related to MENVEO. Additional details were provided as follows: The reporter preferred not to answer the medical history details of the patient. On 3rd June 2011, the patient received the 1st dose of MENVEO vaccine. On 4th September 2015, at 12.26 pm, the patient again received a dose of MENVEO vaccine in the left deltoid, which led to an extra dose administered. On the same day, the patient also received TRUMENBA in the right deltoid intramuscularly. The patient experienced psycho seizures, photosensitivity and she was not able to walk very well at the time of reporting. On 5th September 2015 to 15th September 2015, the patient was hospitalized for duration of 10 days. The patient did not experience any illness at the time of vaccination. The patient was not deceased. The reporter considered the psycho seizure, photosensitivity and walking difficulty to be related to TRUMENBA.


VAERS ID: 620401 (history)  
Form: Version 1.0  
Age: 16.0  
Sex: Female  
Location: New York  
Vaccinated:2016-01-19
Onset:2016-01-19
   Days after vaccination:0
Submitted: 2016-01-20
   Days after onset:1
Entered: 2016-01-22
   Days after submission:2
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. L016428 / 2 RA / IM
MENB: MENINGOCOCCAL B (TRUMENBA) / PFIZER/WYETH M13065 / 1 LA / IM

Administered by: Private       Purchased by: Private
Symptoms: Feeling hot, Hyperhidrosis, Nausea, Pharyngitis, Pyrexia, Sinusitis, Streptococcus test negative
SMQs:, Acute pancreatitis (broad), Agranulocytosis (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Oropharyngeal infections (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Levothyroxine sodium
Current Illness: Pt seen in office 1/21/16 dx with sinusitis and pharyngitis and placed on abx.
Preexisting Conditions: 3/10 autoimmune hypothyroid
Allergies:
Diagnostic Lab Data: Strep test (-)
CDC Split Type:

Write-up: 5 min after the injection pt began to feel very warm, became diaphoretic, and nauseous. Pt advised to lay down and a cool compress was applied to her forehead. Pt was given a freezie pop and she began to feel better within minutes. Pt stayed in office for another 15 min. Pushed fluids when pt got home. That night pt dev a fever. Pt was seen in office 1/21/16 dx with sinusitis and pharyngitis and placed on abx.


VAERS ID: 620487 (history)  
Form: Version 1.0  
Age: 16.0  
Sex: Female  
Location: California  
Vaccinated:2016-01-18
Onset:2016-01-20
   Days after vaccination:2
Submitted: 2016-01-20
   Days after onset:0
Entered: 2016-01-22
   Days after submission:2
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (TRUMENBA) / PFIZER/WYETH M37314 / 1 AR / IM

Administered by: Private       Purchased by: Public
Symptoms: Injection site erythema, Injection site macule
SMQs:, Extravasation events (injections, infusions and implants) (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: No known allergies
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: 8x7 cm very faint pinkish macule distal and lateral to actual injection site. Area was more near mid upper inner extremity rather than deltoid area.


VAERS ID: 620783 (history)  
Form: Version 1.0  
Age: 17.0  
Sex: Female  
Location: Pennsylvania  
Vaccinated:2016-01-19
Onset:2016-01-19
   Days after vaccination:0
Submitted: 2016-01-26
   Days after onset:7
Entered: 2016-01-26
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (TRUMENBA) / PFIZER/WYETH L13514 / 2 LA / IM

Administered by: Private       Purchased by: Public
Symptoms: Activities of daily living impaired, Blood creatine phosphokinase, Differential white blood cell count, Full blood count, Lethargy, Metabolic function test, Pain in extremity, Red blood cell sedimentation rate
SMQs:, Dementia (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Tendinopathies and ligament disorders (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: TYLENOL; MOTRIN; CLARITIN
Current Illness: None
Preexisting Conditions: AB; Asthma
Allergies:
Diagnostic Lab Data: CBC diff; ESR; CMP-12; CPK
CDC Split Type:

Write-up: Pain in arm (of immunization), (B) leg pain, lethargic. Mom had to lift patient to assist out of bed.


VAERS ID: 622027 (history)  
Form: Version 1.0  
Age:   
Sex: Unknown  
Location: Unknown  
Vaccinated:2015-12-01
Onset:0000-00-00
Submitted: 2016-01-28
Entered: 2016-01-29
   Days after submission:1
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Injection site pain
SMQs:, Extravasation events (injections, infusions and implants) (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: US2016008354

Write-up: This case was reported by a physician via sales rep and described the occurrence of injection site pain in a patient who received BEXSERO. In December 2015, the patient received BEXSERO .5 ml. On an unknown date, less than a month after receiving BEXSERO, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was recovered/resolved. It was unknown if the reporter considered the injection site pain to be related to BEXSERO. Additional details provided were as follows: The physician''s office had called the sales representative to report this case. The patient had been vaccinated with BEXSERO within the last month or so who had about 5 days of pain at the injection site after vaccination with BEXSERO. The patient''s gender, lot number and expiration date of the vaccine were unknown.


VAERS ID: 623274 (history)  
Form: Version 1.0  
Age: 19.0  
Sex: Male  
Location: Unknown  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2016-02-01
Entered: 2016-02-01
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Dizziness, Fatigue, Headache
SMQs:, Anticholinergic syndrome (broad), Vestibular disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: US2016009881

Write-up: This case was reported by a physician via call center representative and described the occurrence of headache in a 19-year-old male patient who received BEXSERO. In January 2016, the patient received BEXSERO. In January 2016, 3 days after receiving BEXSERO, the patient experienced headache, dizziness and fatigue. On an unknown date, the outcome of the headache was not recovered/not resolved and the outcome of the dizziness and fatigue were recovered/resolved. It was unknown if the reporter considered the headache, dizziness and fatigue to be related to BEXSERO. Additional details were provided as follows: The patient was grandson of the reporting healthcare professional. The healthcare professional reported that the patient received BEXSERO 2 weeks before the time of reporting and began experiencing headache, fatigue and dizziness 3 days after receiving the vaccine. The healthcare professional reported that the patient has never experienced these types of symptoms before. The healthcare professional reported that the symptoms seemed to go away a few days before the time of reporting but the headache has come back. No further information was reported regarding this administration. The healthcare professional initially called for recommendations of clinical data regarding adverse reactions of BEXSERO. The call was escalated to Vaccine''s Medical Information System.


VAERS ID: 621751 (history)  
Form: Version 1.0  
Age: 25.0  
Sex: Male  
Location: Idaho  
Vaccinated:2016-01-26
Onset:2016-01-26
   Days after vaccination:0
Submitted: 2016-02-03
   Days after onset:8
Entered: 2016-02-03
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (TRUMENBA) / PFIZER/WYETH - / 2 RA / IM

Administered by: Public       Purchased by: Private
Symptoms: Asthenia, Cough, Fatigue, Injection site pain, Myalgia, Pyrexia, Skin discolouration
SMQs:, Rhabdomyolysis/myopathy (broad), Anaphylactic reaction (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Guillain-Barre syndrome (broad), Extravasation events (injections, infusions and implants) (broad), Eosinophilic pneumonia (broad), Hypotonic-hyporesponsive episode (broad), Tendinopathies and ligament disorders (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: None
Current Illness: None
Preexisting Conditions: None
Allergies:
Diagnostic Lab Data: None
CDC Split Type:

Write-up: A lot of pain at the injection. Muscle Pain continued from time of injection to 2/1/2016. Most painful during the first two days (maybe an 8 on a pain scale). Seemed to hurt most in the mornings. Fever + symptoms from 1/26/2016-1/30/2016. 100+ degrees only on first day. Extreme fatigue and weakness during the whole duration. Developed a strenuous cough 1/28/2016-1/30/2016. Discoloration of the skin 1/30/2016-2/1/2016.


VAERS ID: 621757 (history)  
Form: Version 1.0  
Age: 18.0  
Sex: Female  
Location: Unknown  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2016-01-25
Entered: 2016-02-03
   Days after submission:9
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (TRUMENBA) / PFIZER/WYETH - / UNK UN / UN
MNQ: MENINGOCOCCAL CONJUGATE (MENACTRA) / SANOFI PASTEUR - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Anaphylactoid reaction, Dyspnoea, Pyrexia, Throat tightness
SMQs:, Anaphylactic reaction (narrow), Angioedema (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Anaphylactic/anaphylactoid shock conditions (narrow), Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Cardiomyopathy (broad), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness: Unk
Preexisting Conditions: Unknown
Allergies:
Diagnostic Lab Data: Lab tests unknown
CDC Split Type: 2015SA217093

Write-up: Initial unsolicited report received from a physician via other company (Pfizer) on 17 December 2015. Manufacturer report number: 2015444928. This case involves an 18-year-old female patient who was vaccinated with a dose of MENACTRA (batch number, expiration date, dose, dose number, route and site of administration were not reported) and a dose of TRUMENBA (batch number, expiration date, dose, dose number, route and site of administration were not reported) on an unspecified date at the same time, visit. The patient medical history and concomitant medication were not reported. On an unspecified date, following the vaccination, the patient experienced fever, throat was closing up could not breathe which was like an anaphylactic response. It was reported that, on an unspecified date, the patient had to go to the emergency room. Laboratory investigation and corrective treatment were not reported. The outcome of the event was not reported. The reporter was not aware of causality of suspect vaccine with adverse event. Upon internal review, company assessed the event of it was like an anaphylactic response, throat constriction and could not breathe as serious and important medical event. List of documents held by sender: none.


VAERS ID: 623518 (history)  
Form: Version 1.0  
Age:   
Sex: Unknown  
Location: Unknown  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2016-02-03
Entered: 2016-02-03
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Pain
SMQs:

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: US2016GSK015454

Write-up: This case was reported by a nurse via sales rep and described the occurrence of pain in a patient who received BEXSERO. On an unknown date, the patient received BEXSERO .5 ml. On an unknown date, 7 days after receiving BEXSERO, the patient experienced pain. On an unknown date, the outcome of the pain was unknown. It was unknown if the reporter considered the pain to be related to BEXSERO. Additional details were received as follows: The reporter stated that, 2 patients experienced soreness one week out after the vaccination with BEXSERO. The reporter stated that, very little information was known about the event was known and all other information included as batch number of vaccine, age of patient, date of vaccination, initials of patients and expiry date of vaccine were unknown. This case has been linked with the case US2016GSK015440 for the 1st patient reported by the same reporter.


Result pages: prev   24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42   next

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=33&VAX=MENB


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166